Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

Lisdexamfetamine in Binge Eating Disorder of Moderate or Greater Severity

The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder

Inclusion Criteria:

• Patients will meet DSM-IV criteria for BED for at least the last 6 months

Exclusion Criteria:

• Women who are pregnant or lactating and women of childbearing potential who are not taking adequate contraceptive measures. If there is a possibility a female subject might be pregnant, a pregnancy test will be performed. (All women of childbearing potential will have a negative pregnancy test before entering the study.)
• Subjects who are displaying clinically significant suicidality or homicidality.
• A current or recent (within 6 months of the start of study medication) DSM-IV diagnosis of substance abuse or dependence